Acute Mania — Elevated YMRS at Baseline
Placeholder: patient presents with severe manic symptoms and high YMRS.
- ~32: Baseline YMRS (Placeholder severe range)
- ↓↓: Sleep need (Placeholder short sentence)
- High: Racing thoughts (Placeholder short sentence)
- Low: Insight (Placeholder short sentence)
Recognizing the acute manic episode
Placeholder: elevated mood, pressured speech, and grandiosity dominate presentation.
Choosing an Antipsychotic Agent
Placeholder: three agents differ in sedation and speed of action.
- Sedating: Quetiapine (Placeholder short sentence)
- Fast-acting: Olanzapine (Placeholder short sentence)
- Activating: Aripiprazole (Placeholder short sentence)
- Tolerability: Choice driver (Placeholder short sentence)
Agent trade-offs in acute mania
Placeholder: sedation, metabolic risk, and speed guide agent choice.
Dose Titration — Days 1 Through 3
Placeholder: dose is escalated stepwise over the first days.
- 3 days: Titration span (Placeholder short sentence)
- Expected: Sedation rise (Placeholder short sentence)
- Vitals, EPS: Monitoring (Placeholder short sentence)
- Target dose: Goal (Placeholder short sentence)
Stepwise dose escalation
Placeholder: rapid but cautious titration reduces early dropout.
Symptom Response — Days 4 Through 7
Placeholder: agitation and racing thoughts begin to settle.
- Visible: YMRS drop (Placeholder short sentence)
- Improving: Sleep return (Placeholder short sentence)
- ≥50% drop: Response def. (Placeholder short sentence)
- Monitored: Side effects (Placeholder short sentence)
Tracking early clinical response
Placeholder: symptom trajectory guides continued dosing decisions.
YMRS Remission Assessment
Placeholder: remission defined as YMRS score of 12 or below.
- YMRS ≤12: Remission cut (Placeholder short sentence)
- ~2 weeks: Timeframe (Placeholder short sentence)
- Continue dose: Maintenance (Placeholder short sentence)
- Ongoing: Relapse watch (Placeholder short sentence)
Defining and confirming remission
Placeholder: sustained low YMRS confirms treatment success.
Placeholder: remission is confirmed by sustained YMRS ≤12 over time.